Changing prevalence and treatment outcomes of patients with p16 human papillomavirus related oropharyngeal squamous cell carcinoma in New Zealand

British Journal of Oral and Maxillofacial Surgery - Tập 54 - Trang 898-903 - 2016
H.J. Kwon1, H.D. Brasch2,3, S. Benison3, R.W. Marsh2,4, T. Itinteang2, G.W. Titchener1, J. Evans5, S.T. Tan2,6
1Department of Otolaryngology - Head and Neck Surgery, Wellington Regional Hospital, Wellington, New Zealand
2Gillies McIndoe Research Institute, Wellington, New Zealand
3Department of Pathology, Hutt Hospital, Wellington, New Zealand
4Auckland University, Auckland, New Zealand
5Wellington Blood and Cancer Centre, Wellington Regional Hospital, Wellington, New Zealand
6Wellington Regional Plastic, Maxillofacial & Burns Unit, Hutt Hospital, Wellington, New Zealand

Tài liệu tham khảo

Chaturvedi, 2011, Human papillomavirus (HPV) and rising oropharyngeal cancer incidence in the United States, J Clin Oncol, 29, 4294, 10.1200/JCO.2011.36.4596 Hong, 2010, Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets, Vaccine, 28, 3269, 10.1016/j.vaccine.2010.02.098 Näsman, 2009, Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?, Int J Cancer, 125, 362, 10.1002/ijc.24339 Ng, 2014, Smoking prevalence and cigarette consumption in 187 countries, 1980-2012, JAMA, 311, 183, 10.1001/jama.2013.284692 WHO, 2014 Pytynia, 2014, Epidemiology of HPV-associated oropharyngeal cancer, Oral Oncol, 50, 380, 10.1016/j.oraloncology.2013.12.019 Elwood, 2014, Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia, Cancer Epidemiol, 38, 16, 10.1016/j.canep.2013.12.004 Tan, 2015, Characterisation of subpopulations of myeloid cells in infantile haemangioma, J Clin Pathol, 68, 571, 10.1136/jclinpath-2014-202846 Ministry of Health, 2012 Ministry of Health, 2011 D'Souza, 2009, Oral sexual behaviors associated with prevalent oral human papillomavirus infection, J Infect Dis, 199, 1263, 10.1086/597755 Doorbar, 2012, The biology and life-cycle of human papillomaviruses, Vaccine, 30, F55, 10.1016/j.vaccine.2012.06.083 Heck, 2010, Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium, Int J Epidemiol, 39, 166, 10.1093/ije/dyp350 Kreimer, 2013, Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study, Lancet, 382, 877, 10.1016/S0140-6736(13)60809-0 Rissel, 2003, Sex in Australia: First experiences of vaginal intercourse and oral sex among a representative sample of adults, Aust NZ J Public Health, 27, 131, 10.1111/j.1467-842X.2003.tb00800.x Psutka, 2012, Sexual health, risks, and experiences of New Zealand university students: findings from a national cross-sectional study, NZ Med J, 125, 62 Chelimo, 2015, Sociodemographic differences in the incidence of oropharyngeal and oral cavity squamous cell cancers in New Zealand, Aust NZ J Public Health, 39, 162, 10.1111/1753-6405.12352 Chaturvedi, 2008, Incidence trends for human Papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States, J Clin Oncol, 26, 612, 10.1200/JCO.2007.14.1713 Kian Ang, 2010, Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, 363, 24, 10.1056/NEJMoa0912217 Westra, 2012, The morphologic profile of hpv-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management, Head Neck Pathol, 6, S48, 10.1007/s12105-012-0371-6 Giuliano, 2011, Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males, N Engl J Med, 364, 401, 10.1056/NEJMoa0909537 Joura, 2012, Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data, BMJ, 344, e1401, 10.1136/bmj.e1401 Herrero, 2013, Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica, PLoS One, 8, e68329, 10.1371/journal.pone.0068329 Lesnikova, 2009, p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens, Diagn Pathol, 4, 22, 10.1186/1746-1596-4-22